Long anticipated – now available: the neurology portfolio for the UNIQO 160, our all-in-one automated IFA system, has been expanded by nine more indirect immunofluorescence assays (IFA). While the previous portfolio primarily contained classic Euroimmun BIOCHIP Mosaics with different tissue sections as substrates, these new additions are highly relevant monospecific IFA with a particular focus […]
This milestone is much more than just a number: Every single installation stands for a laboratory that decided to leave manual processes behind and to opt for a solution that combines efficiency, safety, scalability and automation aspects. Today, the laboratory management system EUROLabOffice and its successor EUROLabOffice 4.0 are installed in more than 60 countries
Reliability, versatility and usability of automation solutions are crucial in diagnostic laboratories. The random access device IDS i20 joins the IDS-i10 and IDS-iSYS in the i-series and was developed to fulfil precisely these requirements for the processing of chemiluminescence immunoassays (ChLIA). This makes it possible to maximise standards even with high sample numbers, to minimise
The state-of-the-art UNIQO 160 is EUROIMMUN’s all-in-one system reducing manual working steps, increasing productivity and ensuring maximum diagnostic precision. Full automation of indirect immunofluorescence assays (IFA) from the primary sample to the result proposal makes the instrument an ideal choice for laboratories wanting to take their IFA workflow to the next level. The UNIQO 160
Diagnostics using indirect immunofluorescence tests (IFA) cover a wide range of indications and therefore have long been the gold standard in the laboratory. However, despite the many diagnostic applications of this method, evaluating fluorescence patterns can be a real challenge. More than half of the specific patterns that can be found in the evaluation of
